1374772-02-7

Basic information

• Product Name: (1S,2S,3R,4R,5S,6R)-2,3,4,5-tetrakis(benzyloxy)-6-(di-n-nonylamino)cyclohexanol
• Synonyms: (1S,2S,3R,4R,5S,6R)-2,3,4,5-tetrakis(benzyloxy)-6-(di-n-nonylamino)cyclohexanol
• CAS NO: 1374772-02-7
• Molecular Weight: 792.155
• Mol File: 1374772-02-7.mol

Chemical Properties

• CAS DataBase Reference: (1S,2S,3R,4R,5S,6R)-2,3,4,5-tetrakis(benzyloxy)-6-(di-n-nonylamino)cyclohexanol(CAS DataBase Reference)
• NIST Chemistry Reference: (1S,2S,3R,4R,5S,6R)-2,3,4,5-tetrakis(benzyloxy)-6-(di-n-nonylamino)cyclohexanol(1374772-02-7)
• EPA Substance Registry System: (1S,2S,3R,4R,5S,6R)-2,3,4,5-tetrakis(benzyloxy)-6-(di-n-nonylamino)cyclohexanol(1374772-02-7)

Safety Data

• Hazardous Substances Data: 1374772-02-7(Hazardous Substances Data)

Upstream product

• 949887-66-5 (-)-(1S,2R,3S,4R,5R,6S)-2-amino-3,4,5,6-tetrakisbenzyloxycyclohexanol 
• 124-19-6 nonan-1-al 

Downstream Products

• 1374772-01-6 (1S,2S,3S,4R,5S,6S)-6-(di-n-nonylamino)cyclohexane-1,2,3,4,5-pentaol hydrochloride 

Relevant articles and documents

Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease

Amino-myo-inositol derivatives have been found to be potent inhibitors of glucocerebrosidase (GCase), the β-glucosidase enzyme deficient in Gaucher disease (GD). When tested using lymphoblasts derived from patients with GD homozygous for N370S or L444P mu